Literature DB >> 30270016

Attitudes toward prenatal screening for chromosomal abnormalities: A focus group study.

Sarah Munro1, Julie Sou2, Wei Zhang3, Tima Mohammadi2, Logan Trenaman3, Sylvie Langlois4, Aslam H Anis5.   

Abstract

BACKGROUND: While discrete choice experiments (DCEs) are well established methods to ascertain patient preferences, there is limited literature describing use of qualitative methods in DCE design. AIM: This article provides a case study of the qualitative research process for developing the conceptual attributes for a DCE for prenatal screening and diagnosis.
METHODS: Participants were recruited through posters and social media. Four in-depth, semi-structured focus groups with pregnant women and their partners/support people were conducted in Metro Vancouver.
FINDINGS: Our analysis indicates that choosing prenatal screening and diagnosis involves four intertwined decisions: whether to undergo screening and testing, which screening test to take, which diagnostic test to take, and what to do with a positive diagnosis. The factors that are important to women and their partners vary depending on the decision and include: time of diagnosis, information on conditions tested, false positives, cost, the invasiveness of the test, and potential harm to woman and baby. DISCUSSION: Findings suggest that certain attributes were more salient for screening versus diagnostic tests. Preferences were often shaped by a woman's perceived ability to care for a child with a genetic anomaly, personal risk factors, parity, views on termination, and perceptions on public or private coverage. Participants valued mental well-being and demonstrated a willingness to trade-off on certain attributes in order to minimize stress or anxiety during pregnancy.
CONCLUSION: Study findings will be used to inform DCE attributes, levels, and choice questions. Findings will be important for policy decisions surrounding prenatal testing.
Copyright © 2018 Australian College of Midwives. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Choice behavior; Health knowledge, attitudes; Patient preference; Pregnancy; Prenatal diagnosis/psychology

Mesh:

Year:  2018        PMID: 30270016     DOI: 10.1016/j.wombi.2018.09.006

Source DB:  PubMed          Journal:  Women Birth        ISSN: 1871-5192            Impact factor:   3.172


  1 in total

1.  Pharmacist checklist and resource guide for mifepristone medical abortion: User-centred development and testing.

Authors:  Nevena Rebic; Sarah Munro; Wendy V Norman; Judith A Soon
Journal:  Can Pharm J (Ott)       Date:  2021-05-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.